一项为期12周的随机、开放标签、平行组试验，旨在研究托吡酯对精神分裂症患者在奥氮平治疗期间体重增加的限制作用。 - Suppr

A 12-week, randomized, open-label, parallel-group trial of topiramate in limiting weight gain during olanzapine treatment in patients with schizophrenia.

作者信息

Kim Jin Hun, Yim Seon Jin, Nam Jung Hyun

出版信息

Schizophr Res. 2006 Feb 15;82(1):115-7. doi: 10.1016/j.schres.2005.10.001. Epub 2005 Dec 2.

DOI:10.1016/j.schres.2005.10.001

PMID:16326074

Abstract

摘要

相似文献

A 12-week, randomized, open-label, parallel-group trial of topiramate in limiting weight gain during olanzapine treatment in patients with schizophrenia.

Schizophr Res. 2006 Feb 15;82(1):115-7. doi: 10.1016/j.schres.2005.10.001. Epub 2005 Dec 2.

Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate.

Psychiatry Clin Neurosci. 2005 Oct;59(5):613-5. doi: 10.1111/j.1440-1819.2005.01424.x.

Influence of topiramate on olanzapine-related weight gain in women: an 18-month follow-up observation.

J Clin Psychopharmacol. 2007 Oct;27(5):475-8. doi: 10.1097/jcp.0b013e31814b98e5.

Topiramate for reversing atypical antipsychotic weight gain.

J Am Acad Child Adolesc Psychiatry. 2001 Dec;40(12):1364. doi: 10.1097/00004583-200112000-00003.

Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.

Ann Pharmacother. 2010 Apr;44(4):668-79. doi: 10.1345/aph.1M550. Epub 2010 Mar 16.

Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.

Am J Psychiatry. 2008 Mar;165(3):352-8. doi: 10.1176/appi.ajp.2007.07010079. Epub 2008 Feb 1.

Topiramate's effectiveness on weight reduction in overweight/obese persons with schizophrenia: study protocol for a randomized controlled trial.

Trials. 2017 Sep 20;18(1):435. doi: 10.1186/s13063-017-2162-6.

A low TSH profile predicts olanzapine-induced weight gain and relief by adjunctive topiramate in healthy male volunteers.

Psychoneuroendocrinology. 2016 Apr;66:101-10. doi: 10.1016/j.psyneuen.2015.12.024. Epub 2016 Jan 4.

Influence of topiramate on olanzapine-related adiposity in women: a random, double-blind, placebo-controlled study.

J Clin Psychopharmacol. 2005 Jun;25(3):211-7. doi: 10.1097/01.jcp.0000162806.46453.38.

Comment: Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.

Ann Pharmacother. 2010 Jul-Aug;44(7-8):1349-50; author reply 1350-1. doi: 10.1345/aph.1M550a. Epub 2010 Jun 29.

引用本文的文献

A Double-Blind, Placebo-Controlled Study of Adjunctive Topiramate in Adolescents With Co-Occurring Bipolar and Cannabis Use Disorders.

JAACAP Open. 2024 Sep 7;2(4):290-300. doi: 10.1016/j.jaacop.2024.08.002. eCollection 2024 Dec.

Pharmacological interventions for prevention of weight gain in people with schizophrenia.

Cochrane Database Syst Rev. 2022 Oct 3;10(10):CD013337. doi: 10.1002/14651858.CD013337.pub2.

Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries.

Cochrane Database Syst Rev. 2021 Feb 16;2(2):CD013281. doi: 10.1002/14651858.CD013281.pub2.

Atypical antipsychotics: A review on the prevalence, monitoring, and management of their metabolic and cardiovascular side effects.

Ment Health Clin. 2016 Jun 29;6(4):178-184. doi: 10.9740/mhc.2016.07.178. eCollection 2016 Jul.

Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials.

Neuropsychiatr Dis Treat. 2016 Dec 15;12:3221-3236. doi: 10.2147/NDT.S125367. eCollection 2016.

Obesity in children with autism spectrum disorder.

Harv Rev Psychiatry. 2014 Mar-Apr;22(2):93-103. doi: 10.1097/HRP.0000000000000031.

Interventions for the metabolic syndrome in schizophrenia: a review.

Ther Adv Endocrinol Metab. 2012 Oct;3(5):141-62. doi: 10.1177/2042018812458697.

Familial vulnerability to an unusual cognitive adverse effect of topiramate: Discussion of mechanisms.

Indian J Psychiatry. 2010 Jul;52(3):260-3. doi: 10.4103/0019-5545.70986.

Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems.

Cochrane Database Syst Rev. 2010 Dec 8;2010(12):CD006629. doi: 10.1002/14651858.CD006629.pub2.

Management of antipsychotic-related weight gain.

Expert Rev Neurother. 2010 Jul;10(7):1175-200. doi: 10.1586/ern.10.85.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

A 12-week, randomized, open-label, parallel-group trial of topiramate in limiting weight gain during olanzapine treatment in patients with schizophrenia.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献